Skip to contentFLETCHER R JOHN — ClearPoint Neuro, Inc. insider: 210 transactions · InsiderLensFLETCHER R JOHN
- Director at PANACOS PHARMACEUTICALS, INC. · on record since Jan 26, 2006
- Director at AUTOIMMUNE INC · on record since May 19, 2006
- Director at AXCELIS TECHNOLOGIES INC · on record since Jul 5, 2006
- Director at SPECTRANETICS CORP · on record since Jan 30, 2007
- Director at CANCER GENETICS, INC · on record since May 24, 2021
- Director at REPRO MED SYSTEMS INC · on record since Apr 1, 2026
- Chairman of the Board at REPRO MED SYSTEMS INC · on record since Apr 1, 2026
- Director at ClearPoint Neuro, Inc. · on record since Apr 2, 2026
- Director at NASTECH PHARMACEUTICAL CO INC · on record since Jul 18, 2011
- Director at NMT MEDICAL INC · on record since Jun 24, 2004
- Director at OPTION CARE INC/DE · on record since Apr 26, 2022
Insider trading activity of FLETCHER R JOHN
- Transactions on record
- 210
- since Oct 24, 2003
- Open-market buys
- 20
- $780K
- Open-market sells
- 11
- $3.8M
- Companies traded
- 10
- last filing Jul 1, 2026
Figures computed from official regulatory filings — methodology.
Companies where FLETCHER R JOHN has traded
- REPRO MED SYSTEMS INC35 tx · $839K · Jul 1, 2026
- ClearPoint Neuro, Inc.53 tx · $383.1K · May 26, 2026
- OPTION CARE INC/DE6 tx · May 21, 2025
- CANCER GENETICS, INC12 tx · $106.7K · Jan 19, 2023
- AXCELIS TECHNOLOGIES INC44 tx · $3.5M · Feb 17, 2021
- SPECTRANETICS CORP28 tx · $7.9M · Aug 11, 2017
- NASTECH PHARMACEUTICAL CO INC1 tx · $15.8K · Sep 7, 2011
- AUTOIMMUNE INC18 tx · May 22, 2009
- PANACOS PHARMACEUTICALS, INC.11 tx · Jun 30, 2008
Track record of FLETCHER R JOHN
Statistical track record
Free- Open-market buys
- 20
- Last buy
- May 24, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of FLETCHER R JOHN
Co-insiders of FLETCHER R JOHN
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
2 tx · Dec 16, 2004
ACKERMAN SAMUEL KPANACOS PHARMACEUTICALS, INC.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 1, 2026 | Award | 5,357 | 4.20 USD | — | SEC |
| May 26, 2026 | AwardD | 12,820 | 0.00 USD | $0 | SEC |
| May 21, 2026 | Exercise | 12,417 | — | — | SEC |
| May 21, 2026 | ExerciseD | -12,417 | — | — | SEC |
| Apr 2, 2026 | Award | 1,270 | 9.10 USD | $11.6K | SEC |
| Apr 1, 2026 | Award | 5,208 | 4.32 USD | $22.5K | SEC |
| Jan 5, 2026 | Award | 422 | 13.68 USD | $5.8K | SEC |
| Jan 2, 2026 | Award | 3,872 | 5.81 USD | $22.5K | SEC |
| Oct 2, 2025 | Award | 265 | 21.79 USD | $5.8K | SEC |
| Oct 2, 2025 | Award | 5,874 | 3.83 USD | $22.5K | SEC |
| Jul 2, 2025 | Award | 6,284 | 3.58 USD | $22.5K | SEC |
| Jul 2, 2025 | Award | 484 | 11.94 USD | $5.8K | SEC |
| May 23, 2025 | AwardD | 12,417 | 0.00 USD | $0 | SEC |
| May 21, 2025 | OtherD | -3,566 | — | — | SEC |
| May 21, 2025 | OtherD | -4,266 | — | — | SEC |
| May 21, 2025 | OtherD | -5,666 | — | — | SEC |
| May 19, 2025 | Exercise | 21,093 | — | — | SEC |
| May 19, 2025 | ExerciseD | -21,093 | — | — | SEC |
| Apr 2, 2025 | Award | 486 | 11.89 USD | $5.8K | SEC |
| Apr 2, 2025 | Award | 8,806 | 2.56 USD | $22.5K | SEC |
| Jan 3, 2025 | Award | 375 | 15.38 USD | $5.8K | SEC |
| Jan 3, 2025 | Award | 5,905 | 3.81 USD | $22.5K | SEC |
| Oct 2, 2024 | Award | 515 | 11.21 USD | $5.8K | SEC |
| Oct 1, 2024 | Award | 8,181 | 2.75 USD | $22.5K | SEC |
| Jul 12, 2024 | Award | 8,371 | 2.71 USD | $22.7K | SEC |